Intravitreal triamcinolone acetonide as treatment for extensive exudative retinal detachment
- Department of Ophthalmology, Faculty of Clinical Medicine Mannheim, Ruprecht-Karls-University of Heidelberg, Germany
- Correspondence to: Dr J Jonas Universitäts-Augenklinik, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany: Jost.Jonasaugen.ma.uni-heidelberg.de
- Accepted 1 July 2003
- intravitreal triamcinolone
- exudative retinal detachment
- retinal pigment epithelium
- proliferative vitreoretinopathy
- intraocular
Coats’ disease or entities like Coats’ disease are characterised by a marked exudative retinal detachment with leakage of peripheral retinal vessels, pronounced subretinal deposition of lipids, and eventual progression to total retinal detachment. In some situations, iris neovascularisation can occur, suggesting an angiogenetic component in the course of the disease. In view of the subretinal exudation from the leaking retinal vessels and the possibly neovascular aspect in the disease process, the purpose of this study was to evaluate whether intravitreal triamcinolone acetonide may be helpful in the treatment of Coats’ like diseases. Intravitreal triamcinolone acetonide has recently been shown to have a pronounced anti-oedematous and possibly anti-angiogenic effect in diseases such as diffuse diabetic macular oedema, proliferative diabetic retinopathy, chronic pre-phthisical ocular …
